Lin et al. identify eIF3e as a translational checkpoint that maintains immune tolerance. Deleting eIF3e in B cells drives pathological B–T cell interactions, lymphoproliferative disease, and lymphoma, highlighting translational control as a critical mechanism protecting against immune dysregulation and cancer.
